Mortality News and Research

RSS

Is monkeypox a global public-health emergency?

A summary of available knowledge on the monkeypox virus including pathogenicity, risk to the human population, and strategies that can help limit its spread.

20 Jul 2022

Research highlights the impact of social determinants of health on hypertension control

A research article published this month in the Mayo Clinic Proceedings highlights the significant impact of social determinants of health on patients' ability to sustain control of hypertension.

20 Jul 2022

Fourth dose of Pfizer mRNA COVID vaccine protective against variants and symptomatic infection

Researchers evaluate the efficacy of three- and four-dose regimens of a mRNA-based COVID-19 vaccine in reducing the risk of symptomatic infection.

20 Jul 2022

Smoking increases risk of severe COVID-19 outcomes in hospitalized patients

New research assessed the association of smoking with COVID-19 complications.

20 Jul 2022

New score shows improved prediction of mortality after acute kidney injury

Acute kidney injury (AKI) occurs commonly in critically ill patients admitted to the intensive care unit (ICU) and is associated with high morbidity and mortality.

20 Jul 2022

NHS Breast Screening Programme confers only a low risk of overdiagnosis

In the UK, breast cancer accounts for 31% of all new cancers diagnosed in women each year, with cases having increased by 4% in the last decade.

20 Jul 2022

New vaccine shows promise to fight Lassa virus

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever.

19 Jul 2022

CDC experts update on monkeypox in the United States

Scientists working with the CDC provide the latest information about monkeypox in the U.S.

19 Jul 2022

Study shows how a critical Lassa virus protein drives infection

Lassa fever is a viral illness that is far too common in West Africa. Although it can have a mortality rate of 15 percent in severe cases, up to 90% in pregnant women, and causes deafness in a quarter of survivors, there is no vaccine or antiviral to protect against Lassa virus.

19 Jul 2022

Elephant genes could offer new clues to preventing cancer development

Scientists modeling the cancer-suppressing p53 gene identify how the 20 different molecules unique to elephants get activated for increased sensitivity and response against carcinogenic conditions - with implications for cancer treatments in humans.

19 Jul 2022

What is the optimal alcohol consumption level to minimize health loss?

Researchers performed a population-scale analysis of alcohol consumption by amount, age, gender, region, and year to estimate the theoretical minimum risk exposure level (TMREL) and the non-drinker equivalence (NDE).

19 Jul 2022

Study finds decline in cardiovascular mortality rates over the last 20 years, but racial disparities remain

While it's well-established that Black adults experience a disproportionately high burden of cardiovascular risk factors and disease in comparison to white adults in the United States, few gender-based analyses of recent national trends exist.

19 Jul 2022

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Investigators examined the effectiveness of two, three, and four SARS-CoV-2 vaccine doses during the Omicron prevalent phases.

19 Jul 2022

Should siRNA-based antivirals be added to the COVID toolbox?

A recent study reviewed the existing treatment modalities, including vaccines and antivirals, for SARS-CoV-2 infection.

19 Jul 2022

Sex matters when it comes to immune responses to vaccines and viral infections

A review published in Frontiers in Aging analyzed the sex differences in the safety, effectiveness, and immunogenicity of influenza and COVID-19 vaccines in older individuals. It also analyzed the way sex brings about the modification of the impact of age-related factors on vaccination.

18 Jul 2022

Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Patients hospitalized with COVID-19 with high estimated blood viscosity are at higher risk of death from complications. High blood viscosity impairs flow to small vessels and increases the risk of blood clots. This measure of blood thickness can be used as a predictor of mortality.

18 Jul 2022

Mortality News and Research

Is monkeypox a global public-health emergency?

Research highlights the impact of social determinants of health on hypertension control

Fourth dose of Pfizer mRNA COVID vaccine protective against variants and symptomatic infection

Smoking increases risk of severe COVID-19 outcomes in hospitalized patients

New score shows improved prediction of mortality after acute kidney injury

NHS Breast Screening Programme confers only a low risk of overdiagnosis

New vaccine shows promise to fight Lassa virus

CDC experts update on monkeypox in the United States

Study shows how a critical Lassa virus protein drives infection

Elephant genes could offer new clues to preventing cancer development

What is the optimal alcohol consumption level to minimize health loss?

Study finds decline in cardiovascular mortality rates over the last 20 years, but racial disparities remain

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Should siRNA-based antivirals be added to the COVID toolbox?

Sex matters when it comes to immune responses to vaccines and viral infections

Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Infant formula marketing directly affects breastfeeding rates

Researchers develop a cardiovascular disease risk score specific to the Latin American and Caribbean region

Scientists develop an improved pharmaceutical drug for the treatment of atrial fibrillation

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News